Nelson Advisors have researched 20 future Healthtech and MedTech leaders in 20 European countries, highlighting the founders, scientists and technologists building innovative solutions and companies. In addition to the 20 x 20 Series, we have also predicted 3 HealthTech and MedTech hubs across Europe with the potential to become centres of excellence.

The Italian life sciences ecosystem has entered a period of profound structural transformation, transitioning from a cluster of high-quality specialized manufacturers into a primary engine of European medical innovation. Historically recognized as the fourth-largest medical device market in Europe, Italy is now characterized by a surge in venture capital activity, strategic international partnerships, and a regulatory environment that is increasingly favorable to high-growth